Javed Anees: Asundexian – A New Era in Secondary Stroke Prevention
Javed Anees, Medical Consultant at Government of Kerala, shared a post on LinkedIn:
“Asundexian (Sunarbo): A New Era in Secondary Stroke Prevention
The FDA approval of asundexian on 9 November 2026 marks a significant milestone in antithrombotic therapy.
As the first-in-class oral Factor XIa inhibitor, asundexian introduces a novel strategy to reduce thrombin amplification and pathological thrombosis while potentially preserving physiological hemostasis.
The pivotal OCEANIC-STROKE Phase III trial, involving 12,327 patients, demonstrated a 26% relative reduction in recurrent ischemic stroke (6.2% vs 8.4%; HR 0.74) when asundexian 50 mg once daily was added to antiplatelet therapy.
Importantly, overall ISTH major bleeding was not significantly increased (1.9% vs 1.7%), although bleeding precautions remain essential.
The approval applies to adults following recent qualifying noncardioembolic ischemic stroke or high-risk TIA, in combination with antiplatelet therapy.
A crucial distinction comes from the negative OCEANIC-AF trial: asundexian must not replace established anticoagulation for atrial fibrillation.
The clinical significance extends beyond a new drug-it represents a new therapeutic target in secondary stroke prevention.
Appropriate patient selection, bleeding-risk assessment and integration with existing antiplatelet strategies will determine its place in clinical practice.”
More posts featuring Javed Anees on Hemostasis Today.
-
Nov 12, 2026, 10:30Nancy Di Salvo: Protecting Access to IVIG and SCIG – A Call for Continued EU Recognition
-
Nov 12, 2026, 10:28Ali Hammed: Should DOAC Use Exclude Patients From Thrombolysis After Ischemic Stroke?
-
Nov 12, 2026, 10:21Aseem Kumar Tiwari: The Molecular Dimension of HLA Matching
-
Nov 12, 2026, 10:18Sarah Connolly: Developing Advanced Haematology Services in Cancer Care
-
Nov 12, 2026, 10:13Carlos Esteban Gasko: Restrictive Transfusion in Critical Care
-
Nov 12, 2026, 10:07Samin Mohsenian: Advancing Care in Rare Bleeding Disorders
-
Nov 12, 2026, 10:03Influenza Vaccination in Patients With ITP – ITP Support Association
-
Nov 12, 2026, 10:00Akshat Jain: Asundexian for Recurrent Stroke Prevention
-
Nov 12, 2026, 09:57Romy Meier: From Research to New Scientific Perspectives on HIT and VITT